Aspirin

Many doctors recommend regular use of aspirin to lower the risk of heart attack

Aspirin helps fight some colorectal cancers: US study

Aspirin can help prolong the life of patients suffering from colorectal cancer tumours with a specific genetic mutation, according to a new study released Thursday.
 

Aspirin helps fight some colorectal cancers: US study

Aspirin can help prolong the life of patients suffering from colorectal cancer tumours with a specific genetic mutation, according to a new study released Thursday.
 

Fried food raises stroke risk in older women

Older women who eat high amounts of the kind of fat found in fried foods and baked goods face a greater risk of stroke than women who eat lower fat diets, a US study suggested.
 

Aspirin could beat cancer spread: Australian study

Aspirin and other household drugs may inhibit the spread of cancer because they help shut down the chemical "highways" which feed tumours, Australian researchers announced on Tuesday.
 

Aspirin not worth risks for healthy women: study

NEW YORK (Reuters Health) - Aspirin is a bad bargain for healthy women trying to stave off heart attacks or strokes, although it's commonly used for that purpose, according to Dutch researchers.
 

Bayer/J&J anti-clot drug cuts death in heart study

ORLANDO, Florida (Reuters) - Low doses of Bayer AG and Johnson & Johnson's Xarelto blood clot preventer cut the risk of death by more than 30 percent when used on top of standard blood thinners in patients with acute coronary syndrome, according to data from a study released on Sunday.
 

Aspirin 'slashes hereditary bowel cancer rate'

Long-term, daily doses of aspirin led to a fall of some 60 percent in cases of colorectal cancer among people with an inherited risk of this disease, the journal The Lancet reported on Friday.
 

Aspirin slashes hereditary cancer risk in UK study

LONDON (Reuters) - Taking two aspirin a day for two years reduces the long-term risk of bowel cancer in people with a family history of the disease by around 60 percent, according to a British study published Friday.
 

Daily aspirin tied to risk of vision loss:study

(Reuters) - Seniors who take aspirin daily are twice as likely to have late stage macular degeneration, an age-related loss of vision, than people who never take the pain reliever, according to a European study.
 

Daily aspirin tied to risk of vision loss

NEW YORK (Reuters Health) - Seniors who take aspirin daily are twice as likely to have late stage macular degeneration, an age-related loss of vision, than people who never take the pain reliever, a new European study reports.
 

U.S. unveils ambitious plan to reduce heart attacks

(Reuters) - U.S. health officials are teaming up with insurance companies, pharmacies, health providers and community groups in a campaign to prevent 1 million heart attacks and strokes over five years.
 

No evidence aspirin boosts IVF success: study

NEW YORK (Reuters Health) - Women undergoing in-vitro fertilization (IVF) are often told that a daily aspirin will help boost the odds of success. But a new research review found no evidence the tactic works.
 

AstraZeneca not planning confirmatory Brilinta trial

LONDON (Reuters) - AstraZeneca Plc has no plans to run a clinical trial to confirm the reasons behind a discrepancy between the performance of its newly approved heart drug Brilinta in North America and other parts of the world.
 

Aspirin might interfere with new heart drug

LONDON (Reuters) - A new study backs up a suggestion that high dosages of aspirin may interfere with AstraZeneca's heart drug Brilinta, offering a possible explanation for disappointing results from a study of patients in North America.
 

Does aspirin cut deaths? New study clouds picture

NEW YORKS (Reuters Health) - Despite a lot of excitement about aspirin, scientists can't seem to agree on whether the drug helps healthy people live longer.
 

Aspirin cuts heart attacks, not deaths or strokes

NEW YORK (Reuters Health) - Small doses of aspirin can lower the risk of heart attack in people who never had heart disease, a new look at the medical evidence shows.
 

HeartWare device had 9.2 percent thrombosis rate in trial

BOSTON/CHICAGO (Reuters) - Patients implanted with a mechanical heart-assistance device made by HeartWare International Inc have an unexpectedly high 9.2 percent chance of developing a potentially life-threatening blood clot per year, newly-released data shows.
 

More evidence painkillers lower colon cancer risk

NEW YORK (Reuters Health) - A new study adds to growing evidence that regular use of painkillers like aspirin or ibuprofen may reduce a person's risk of developing colon or rectal cancers - sometimes by as much as 50 percent.
 

Aspirin, other meds linked to stomach bleeding risks

NEW YORK (Reuters Health) - People taking low doses of aspirin to protect their heart may be at risk for stomach bleeding, and those taking both aspirin and other common drugs may have an even higher bleeding risk, according to a new study.
 

Chicago Blackhawks coach recovering in hospital

The Chicago Blackhawks' Stanley Cup winning coach Joel Quenneville was recovering in hospital after being admitted the day before with an ulcer and internal bleeding.